Electrochemical therapy of 74 cases of liver cancer.

Ninety-four patients with primary liver cancer have been treated with electrochemical therapy (ECT) in our hospital. Seventy-four cases were followed up for more than one year, 12 cases for less than one year, and 8 cases were lost. Seventy-four cases of stage II and III liver cancer were divided into three groups. Group A received ECT only, group B received ECT plus transcatheter hepatic artery infusion chemotherapy (TAI) and embolisation (IAE) treatment. Group C received ECT plus systemic chemotherapy. The survival rate at 12 months was 58% for group B patients, which was significantly higher than for group A or C patients. We found ECT to be relatively simple and safe. The main side effect is short-time fever after treatment.